Biggest News Aggregation in the World
📰 Pr Team News

Page 45 - Pr Team News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pr Team. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Non-squamous Non-Small Cell Lung Cancer

Investegate announcements from Junshi Biosciences, Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Non-squamous Non-Small Cell Lung Cancer
United States San Francisco Junshi Bioscience Jie Wang Junshi Biosciences Zhi Li

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination with Chemotherapy as First-Line Treatment for Advanced Non-squamous Non-Small Cell Lung Cancer

--6th approved indication of toripalimab in China, bringing more treatment options to patients with advanced NSCLCSHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd
United States Junshi Bioscience Jie Wang Junshi Biosciences Zhi Li Jianjun Zou

SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile

L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu...
Business Wire Inc Chilean Public Health Institute Instituto De Salud Sinovac Biotech Ltd Pr Team Chilean Public Health Institute Weidong Yin
Source: afp.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science